Last reviewed · How we verify
Liposomal bupivacaine TAP block — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Liposomal bupivacaine TAP block (Liposomal bupivacaine TAP block) — University of Virginia.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Liposomal bupivacaine TAP block TARGET | Liposomal bupivacaine TAP block | University of Virginia | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Liposomal bupivacaine TAP block CI watch — RSS
- Liposomal bupivacaine TAP block CI watch — Atom
- Liposomal bupivacaine TAP block CI watch — JSON
- Liposomal bupivacaine TAP block alone — RSS
Cite this brief
Drug Landscape (2026). Liposomal bupivacaine TAP block — Competitive Intelligence Brief. https://druglandscape.com/ci/liposomal-bupivacaine-tap-block. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab